TCM
ICVX

TCG Crossover Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

TCG Crossover Management’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,703,704
Closed -$58.4M – 38
2023
Q4 		$58.4M Hold
3,703,704
– – 6.47% 3
2023
Q3 		$28.7M Hold
3,703,704
– – 4.23% 10
2023
Q2 		$36.8M Buy
+3,703,704
New +$29.6M 6.03% 6

TCG Crossover Management's ICVX Position: Q1 2024 in Review

TCG Crossover Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 3,703,704 shares — an estimated $58.4M sold.

TCG Crossover Management first reported a position in ICVX in Q2 2023 and held it in 3 quarters. The position peaked at $58.4M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • TCG Crossover Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • TCG Crossover Management sold 3,703,704 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $58.4M.
  • TCG Crossover Management first reported a position in Icosavax, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • TCG Crossover Management's Icosavax, Inc. Common Stock position peaked at $58.4M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on TCG Crossover Management's 13F filing for Q1 2024, filed 15 May 2024.